FI934625L - Sulfonamidderivat av bentsenfusionerade hydroxisubstituerade cykloalkyl- och heterocykliska ringfoereningar - Google Patents

Sulfonamidderivat av bentsenfusionerade hydroxisubstituerade cykloalkyl- och heterocykliska ringfoereningar Download PDF

Info

Publication number
FI934625L
FI934625L FI934625A FI934625A FI934625L FI 934625 L FI934625 L FI 934625L FI 934625 A FI934625 A FI 934625A FI 934625 A FI934625 A FI 934625A FI 934625 L FI934625 L FI 934625L
Authority
FI
Finland
Prior art keywords
sulfonamidderivat
ringfoereningar
hydroxisubstituerade
heterocykliska
benzenfusionerade
Prior art date
Application number
FI934625A
Other languages
English (en)
Finnish (fi)
Other versions
FI934625A7 (fi
FI934625A0 (fi
Inventor
Anthony Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI934625A0 publication Critical patent/FI934625A0/fi
Publication of FI934625A7 publication Critical patent/FI934625A7/fi
Publication of FI934625L publication Critical patent/FI934625L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Quinoline Compounds (AREA)
FI934625A 1992-10-21 1993-10-20 Sulfonamidderivat av bentsenfusionerade hydroxisubstituerade cykloalkyl- och heterocykliska ringfoereningar FI934625L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96433792A 1992-10-21 1992-10-21

Publications (3)

Publication Number Publication Date
FI934625A0 FI934625A0 (fi) 1993-10-20
FI934625A7 FI934625A7 (fi) 1994-04-22
FI934625L true FI934625L (fi) 1994-04-22

Family

ID=25508435

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934625A FI934625L (fi) 1992-10-21 1993-10-20 Sulfonamidderivat av bentsenfusionerade hydroxisubstituerade cykloalkyl- och heterocykliska ringfoereningar

Country Status (23)

Country Link
US (1) US5641789A (OSRAM)
EP (1) EP0665842A1 (OSRAM)
JP (1) JPH07508534A (OSRAM)
KR (1) KR950704309A (OSRAM)
CN (1) CN1090282A (OSRAM)
AP (1) AP9300578A0 (OSRAM)
AU (1) AU5536794A (OSRAM)
BR (1) BR9307277A (OSRAM)
CA (1) CA2146261A1 (OSRAM)
CZ (1) CZ100095A3 (OSRAM)
FI (1) FI934625L (OSRAM)
HR (1) HRP931297A2 (OSRAM)
HU (1) HUT68323A (OSRAM)
IL (1) IL107294A0 (OSRAM)
MA (1) MA23009A1 (OSRAM)
MX (1) MX9306528A (OSRAM)
NO (1) NO303224B1 (OSRAM)
PL (1) PL308474A1 (OSRAM)
RU (1) RU95109929A (OSRAM)
SI (1) SI9300554A (OSRAM)
TW (1) TW265335B (OSRAM)
WO (1) WO1994008996A1 (OSRAM)
ZA (1) ZA937782B (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5539128A (en) * 1994-11-30 1996-07-23 Pfizer Inc. Processes and intermediates for preparing cis(+)3-[4,6-dihydroxy chroman-3-ylmethyl]-4-methoxyaniline
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
JP3117730B2 (ja) * 1996-09-16 2000-12-18 ファイザー・インク 置換クロマール誘導体を製造するための方法及び中間体
ZA981080B (en) * 1997-02-11 1998-08-12 Warner Lambert Co Bicyclic inhibitors of protein farnesyl transferase
GB9800039D0 (en) * 1998-01-02 1998-03-04 Univ Cardiff Benzyl and benzylidene tetralins and derivatives
RU2182004C1 (ru) * 2001-02-22 2002-05-10 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Лекарственный препарат для парентерального применения
EP1386919A4 (en) * 2001-04-10 2010-03-10 Takara Bio Inc REMEDIES
WO2004035741A2 (en) * 2002-10-17 2004-04-29 Decode Genetics Ehf. Susceptibility gene for myocardial infarction; methods of treatment
US20080293750A1 (en) * 2002-10-17 2008-11-27 Anna Helgadottir Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment
US20060019269A1 (en) * 2002-10-17 2006-01-26 Decode Genetics, Inc. Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment
US7507531B2 (en) * 2002-10-17 2009-03-24 Decode Genetics Chf. Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction
US7851486B2 (en) * 2002-10-17 2010-12-14 Decode Genetics Ehf. Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
EP1670445A2 (en) * 2003-09-17 2006-06-21 Decode Genetics EHF. Methods of preventing or treating recurrence of myocardial infarction
US20100216863A1 (en) * 2004-01-30 2010-08-26 Decode Genetics Ehf. Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment
US8158362B2 (en) * 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
US20060210514A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin protection and moisturizing compositions and method of making the same
CN119912349B (zh) * 2023-10-31 2025-11-21 中国石油天然气股份有限公司 一种可降解凝胶用交联剂、制备方法及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
WO1990015801A1 (en) * 1989-06-22 1990-12-27 Pfizer Inc. Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases

Also Published As

Publication number Publication date
CA2146261A1 (en) 1994-04-28
RU95109929A (ru) 1997-03-20
KR950704309A (ko) 1995-11-17
FI934625A7 (fi) 1994-04-22
HUT68323A (en) 1995-06-28
TW265335B (OSRAM) 1995-12-11
AU5536794A (en) 1994-05-09
BR9307277A (pt) 1999-05-11
MX9306528A (es) 1994-06-30
AP9300578A0 (en) 1995-04-07
HU9302969D0 (en) 1993-12-28
ZA937782B (en) 1995-04-20
EP0665842A1 (en) 1995-08-09
PL308474A1 (en) 1995-08-07
NO951506L (no) 1995-04-20
WO1994008996A1 (en) 1994-04-28
JPH07508534A (ja) 1995-09-21
US5641789A (en) 1997-06-24
HRP931297A2 (en) 1996-08-31
IL107294A0 (en) 1994-01-25
MA23009A1 (fr) 1994-07-01
CN1090282A (zh) 1994-08-03
FI934625A0 (fi) 1993-10-20
SI9300554A (en) 1995-04-30
NO951506D0 (no) 1995-04-20
NO303224B1 (no) 1998-06-15
CZ100095A3 (en) 1995-11-15

Similar Documents

Publication Publication Date Title
FI934648A7 (fi) Foerfarande foer foergasning av avfallsaemnen innehaollande braennbara bestaondsdelar
FI924590A0 (fi) Foerfarande foer framstaellning av laekemedelskorn
FI932012L (fi) Foerfarande foer framstaellning av arylpiperazinyl-heterocykliska foereningar
FI925925L (fi) Foerfarande foer framstaellning av valbart hydrerade osmaeltbara polysackarider
FI934013L (fi) Foerstaerkning av immunreaktion
FI933103A0 (fi) Foerfarande foer blekning av kemisk pappersmassa
FI930281L (fi) Reaktivering av hydroformyleringskatalysatorer
FI934625A0 (fi) Sulfonamidderivat av bentsenfusionerade hydroxisubstituerade cykloalkyl- och heterocykliska ringfoereningar
FI931121L (fi) Bockningspress foer framstaellning av boejda glasrutor
FI932726A0 (fi) Foerfarande foer framstaellning av nickelhydroxid
FI932675A0 (fi) Rullmaskin foer rullning av en pappers- eller kartongbana
FI931553L (fi) Foerfarande foer utvinning av enzymer fraon proenzymer
FI933192A0 (fi) Anordning foer kultivering av mikroorganismer
FI932714L (fi) Propellermodul foer indikering av stroemning
FI932322A7 (fi) Braensleelement foer en kaernreaktor av laettvattentyp
FI934900L (fi) Mellandestillatkompostioner av raoolja
FI932016A7 (fi) Anordning foer pervaporering av vaetskor
FI933976L (fi) Foerfarande foer recyklering av silikonbelagt papper
FI931110A0 (fi) Flerskiktfolier av kopolyamider
FI931712A0 (fi) Foerfarande foer utvinning av en polymeriserbar vaerdeaemnesfraktion
FI932620A0 (fi) Framstaellning av blekningskemikalier foer cellulosamassa
FI932570A7 (fi) Foerfarande foer framstaellning av 2-oxo-1-piperidinylderivat
FI932956L (fi) Koppling foer styrning av en polvaendande koppling
FI920011L (fi) Av roerformade delar bildat vaeggelement
FI934756A7 (fi) Anordning foer avlaegsnande av utstansade delar

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed